In a significant push to reshape the American healthcare landscape, the Centers for Medicare & Medicaid Services (CMS) has announced a major expansion of its outcomes-based payment initiative, the Advancing Chronic Care through Engaging Social and Supportive services (ACCESS) model. Starting next year, the agency will double the scope of the program, adding four new clinical tracks to the existing four, effectively broadening the federal government’s commitment to value-based, tech-enabled care.
This expansion marks a pivotal moment in the ongoing transition from volume-based care—where providers are paid for the quantity of services rendered—to value-based care, which rewards providers for achieving tangible health improvements in their patients.
Main Facts: Doubling Down on Outcomes
The ACCESS model, a 10-year voluntary initiative that officially launched on July 5, is designed to integrate digital health technologies into the management of chronic conditions. By incentivizing the use of remote monitoring and health tech platforms, CMS aims to curb the escalating costs and morbidity associated with long-term illnesses.
Currently, the model focuses on four high-prevalence chronic conditions:
- Hypertension
- Diabetes
- Chronic Musculoskeletal Pain
- Depression
With the addition of four new clinical tracks arriving in 2025, CMS is signaling that the framework is not merely an experimental pilot but a scalable foundation for the future of Medicare. The model functions on a strict pay-for-performance structure: participating organizations receive recurring payments for utilizing health technologies, but these payments are contingent upon meeting specific, pre-defined clinical benchmarks. For instance, in the hypertension track, reimbursement is tethered to demonstrable improvements in patient blood pressure levels, while metabolic tracks rely on lipid panel outcomes.
Chronology of the ACCESS Model
The trajectory of the ACCESS model reflects a deliberate, albeit ambitious, shift in federal health policy:
- Pre-Launch Strategy (2023–2024): CMS engaged in extensive stakeholder feedback, evaluating the efficacy of remote patient monitoring (RPM) and chronic care management (CCM) programs. The goal was to bridge the gap between digital health innovation and traditional fee-for-service reimbursement.
- Official Launch (July 5, 2024): The model officially commenced, attracting early adopters ranging from established healthcare systems to agile digital health startups.
- Initial Participation Phase (Late 2024): The agency vetted and approved over 150 healthcare organizations to participate in the inaugural tracks, including high-profile tech entities like Verily and the wearable technology company Whoop.
- Expansion Announcement (Late 2024/Early 2025): CMS confirmed the addition of four new clinical tracks, set to launch in the coming calendar year, aiming to address a wider array of chronic health burdens.
- Future Outlook (2027 and beyond): The model is slated to run for a full decade, with the current payment structure providing a baseline for financial sustainability through December 31, 2027.
Supporting Data: The Financial Mechanics of Innovation
The financial architecture of the ACCESS model is intentionally granular, designed to reward efficiency while ensuring that providers remain focused on patient outcomes rather than process metrics.
Between July 5, 2024, and the end of 2027, participants are eligible for structured payments:
- Initial Year Care: CMS provides between $180 and $420 per patient for the first year of active technology-enabled care.
- Follow-on Period: To encourage long-term engagement, the model includes a "follow-on" payment range of $90 to $210 per patient.
Despite these figures, the program has faced scrutiny regarding the adequacy of its reimbursement rates. Critics in the digital health sector argue that the costs of maintaining high-touch, tech-enabled care—including software subscriptions, data analytics, and patient coaching—may outstrip these payment caps.
However, the sheer volume of interest suggests that industry players see long-term strategic value in the program. By participating now, companies are positioning themselves as preferred vendors in a government-backed ecosystem that is increasingly hostile to waste and inefficiency.
Official Responses and Strategic Vision
The current administration has been vocal about the necessity of this pivot. HHS Secretary Robert F. Kennedy Jr. has frequently identified the reduction of chronic disease as a primary pillar of his tenure, viewing the ACCESS model as a necessary lever to force the healthcare industry to move away from "sick care" and toward "wellness maintenance."
CMS Administrator Dr. Mehmet Oz has championed the model as a transformative tool that transcends the boundaries of traditional Medicare. During a recent press conference, Dr. Oz emphasized that the model’s success could create a "ripple effect" across the entire American healthcare system.
"As traditional Medicare launches this model—again, paying for outcomes, not for effort or process or some surrogate—you also open up the door for Medicare Advantage, for the Department of Veterans Affairs, for Medicaid patients, and TRICARE patients," Dr. Oz stated. By establishing a rigorous, evidence-based standard for what "good care" looks like, CMS is effectively creating a benchmark that private insurers and other federal health departments are likely to adopt to contain their own rising costs.
Implications: The Future of Digital Health
The expansion of the ACCESS model carries profound implications for the digital health industry and the future of patient care.
1. The Survival of the Fittest
The model’s pay-for-performance requirement acts as a filter. Digital health companies that cannot prove their technology actually improves patient health outcomes will likely be pushed out of the market. This creates a "gold standard" for medical technology, where only platforms with robust clinical validation will be eligible for federal reimbursement.
2. A Shift in Patient Experience
For the Medicare enrollee, this signifies a change in how care is delivered. Rather than sporadic, reactive visits to a physician’s office, patients are increasingly being managed through continuous, data-driven oversight. With wearable devices and remote monitoring, clinicians have a real-time window into a patient’s health, allowing for interventions before a condition escalates into an emergency room visit.
3. Integration Across Payers
If Dr. Oz’s vision comes to fruition, the ACCESS model will serve as the blueprint for private-sector managed care plans. Medicare Advantage plans, which already operate under a value-based framework, will likely look to the ACCESS tracks as a template for their own clinical programs, leading to a more standardized approach to managing chronic conditions across the entire insurance market.
4. Challenges to Sustainability
Despite the optimism, significant hurdles remain. Smaller healthcare providers may struggle to absorb the upfront capital expenditures required to deploy the necessary technology, even with the promise of future CMS payments. Furthermore, the administrative burden of reporting outcomes to CMS can be substantial. For the program to be a resounding success, the agency must balance the need for data rigor with the operational realities of the frontline providers who must implement these workflows.
Conclusion
The expansion of the ACCESS model is more than a policy adjustment; it is a declaration of intent. By doubling the number of chronic conditions covered, CMS is signaling to the market that the era of paying for "effort" is coming to a close.
While the debate over payment adequacy continues, the commitment from over 150 organizations indicates that the industry is ready to bet on a future where health technology is synonymous with clinical success. As the model moves into its next phase, the focus will shift from the mechanics of payment to the quality of the data—and ultimately, the long-term impact on the health of the American population. Whether this model succeeds in fundamentally altering the trajectory of chronic disease will depend on the ability of technology to bridge the gap between data collection and meaningful, life-improving action.
